Markets:

Overview

News

Currencies

International

Treasuries

Wave Life Sciences Ltd. - Ordinary Shares (NQ:WVE)

6.990 -0.420 (-5.67%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 2, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Wave Life Sciences Ltd. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >

These Analysts Revise Their Forecasts On Wave Life Sciences Following Q3 Results ↗

November 11, 2025

Via Benzinga

Wave Life Sciences (WVE) Earnings Transcript ↗

November 10, 2025

Wave Life Sciences (WVE) Earnings Transcript

Via The Motley Fool

Wave Life Sciences Ltd (NASDAQ:WVE) Reports Q3 2025 Earnings Miss, Stock Falls ↗

November 10, 2025

Wave Life Sciences reported mixed Q3 2025 results, missing on revenue and EPS. Despite the financial miss, the biotech highlighted strong clinical progress for its obesity and AATD programs.

Via Chartmill

Topics Earnings

Wave Life Sciences Reports Third Quarter 2025 Financial Results and Provides Business Update

November 10, 2025

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Earnings Scheduled For November 10, 2025 ↗

November 10, 2025

Via Benzinga

Peering Into WAVE Life Sciences's Recent Short Interest ↗

September 12, 2025

Via Benzinga

Wave Life Sciences Tumbled 19% Today, But Not Everyone’s Disappointed – Find Out Why ↗

September 03, 2025

Via Stocktwits

Biotech Sector Soars: Promising Drug Trials Ignite Investor Confidence and Spark Market Rally

November 07, 2025

The biotech sector is currently experiencing a robust rally, a significant turnaround from a period of subdued performance. This resurgence is primarily fueled by a wave of promising drug trial results...

Via MarketMinute

Topics Artificial Intelligence Intellectual Property

A Look Ahead: WAVE Life Sciences's Earnings Forecast ↗

November 07, 2025

Via Benzinga

Wave Life Sciences to Present at Upcoming Investor Conferences

November 07, 2025

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Wave Life Sciences to Present Preclinical Data Supporting Therapeutic Potential of WVE-007 for Obesity at ObesityWeek® 2025

November 04, 2025

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Wave Life Sciences Third Quarter 2025 Financial Results Scheduled for November 10, 2025

November 04, 2025

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Correcting and Replacing Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day

October 29, 2025

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day

October 29, 2025

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Keep an eye on the top gainers and losers in Wednesday's session. ↗

October 29, 2025

Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 29, 2025

Via Benzinga

Deep Dive Into WAVE Life Sciences Stock: Analyst Perspectives (6 Ratings) ↗

October 15, 2025

Via Benzinga

Wave Life Sciences Announces Virtual Research Day on October 29th and Participation at Upcoming Investor Conferences

September 18, 2025

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Top movers analysis one hour before the close of the markets on 2025-09-03: top gainers and losers in today's session. ↗

September 03, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

Forecasting The Future: 7 Analyst Projections For WAVE Life Sciences ↗

September 03, 2025

Via Benzinga

Why Is GSK Partner Wave Life Sciences Stock Trading Lower On Wednesday? ↗

September 03, 2025

Wave Life Sciences shares early WVE-006 trial results in alpha-1 antitrypsin deficiency, reporting durable protein production and favorable safety.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

September 03, 2025

Via Benzinga

Crude Oil Falls Over 2%; Campbell's Earnings Top Estimates ↗

September 03, 2025

Via Benzinga

Wednesday's session: gap up and gap down stocks ↗

September 03, 2025

Today's session on Wednesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

Via Chartmill

Nasdaq Gains Over 100 Points; Dollar Tree Post Upbeat Earnings ↗

September 03, 2025

Via Benzinga

Which stocks are moving before the opening bell on Wednesday? ↗

September 03, 2025

Wondering what's happening in Wednesday's pre-market session? Find an overview in this article.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 03, 2025

Via Benzinga

Wave Life Sciences Announces Positive Update from Ongoing RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency

September 03, 2025

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

This AeroVironment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗

August 04, 2025

Via Benzinga

Beyond The Numbers: 6 Analysts Discuss WAVE Life Sciences Stock ↗

August 04, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.